Virtu KCG Holdings’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Virtu KCG Holdings’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$237K	Buy	+3,096	New	+$260K	0.01%	1964

Other funds holding LKFT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Virtu KCG Holdings's LKFT Position: Q2 2017 in Review

Virtu KCG Holdings opened a new position in Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q2 2017: 3,096 shares worth $237K. The stake represents 0.01% of the portfolio and ranks #1964 among its holdings.

78 funds tracked by Wall St. Rank hold LKFT as of Q2 2017.

Virtu KCG Holdings held 3,096 shares of Lakefront Biotherapeutics American Depositary Shares worth $237K as of Q2 2017.
Lakefront Biotherapeutics American Depositary Shares was a new Virtu KCG Holdings position in Q2 2017.
Lakefront Biotherapeutics American Depositary Shares made up 0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #1964 holding.
78 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.